Pharma

Your Article Summary

See Latest Articles

Biotech needs to embrace “economic reality”, says Amgen
b3c newswire, 03/04/09

The biopharmaceutical industry must embrace the challenges posed by the current financial downturn and transform its way of conducting business in order to survive, says Dr Ran Zheng, Plant Manager of Clinical Operations at Amgen and forthcoming speaker at Informa's BioProcess International European Conference and Exhibition in Dusseldorf, April 2009.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09

Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09

Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09

 See all of Biotechnology